• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉用氨甲环酸治疗产后出血的替代途径:系统检索和叙述性综述。

Alternative routes to intravenous tranexamic acid for postpartum hemorrhage: A systematic search and narrative review.

机构信息

Clinical Trials Unit, London School of Hygiene and Tropical Medicine, London, UK.

Département des maladies des voies respiratoires, Hôpital Foch, Suresnes, France.

出版信息

Int J Gynaecol Obstet. 2022 Jun;158 Suppl 1(Suppl 1):40-45. doi: 10.1002/ijgo.14201.

DOI:10.1002/ijgo.14201
PMID:35762806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9327714/
Abstract

OBJECTIVE

To review available data on tranexamic acid (TXA) plasma concentration needed to inhibit fibrinolysis and the time to achieve this concentration when giving TXA by different routes in humans. To identify ongoing trials assessing alternatives to intravenous TXA administration.

METHODS

We updated two previous systematic reviews by searching MEDLINE, EMBASE, OviSP, and ISI Web of Science from database inception to July 2021. We also searched the WHO International Clinical Trials Registry Platform for ongoing trials to July 2021. Titles and abstracts were screened for relevant trials. Two reviewers independently reviewed and agreed the trials to be included.

RESULTS

Plasma TXA concentrations over 10 mg/L provide near maximal inhibition of fibrinolysis, with concentrations over 5 mg/L providing partial inhibition. Oral TXA tablets take about 1 h to reach a plasma concentration of 5 mg/L in postpartum women. Studies in healthy volunteers and shocked trauma patients show that intramuscular TXA achieves a plasma level of over 10 mg/L within 15 min. One trial is ongoing to determine the pharmacokinetics of intramuscular and oral solution TXA in pregnant women.

CONCLUSION

Intramuscular TXA in healthy volunteers and shocked trauma patients reaches therapeutic concentration rapidly. Oral TXA tablets take too long to reach the minimum therapeutic concentration in postpartum women.

摘要

目的

回顾在人体中通过不同途径给予氨甲环酸(TXA)时,达到抑制纤维蛋白溶解所需的 TXA 血浆浓度数据,并确定达到该浓度所需的时间。确定正在评估 TXA 静脉给药替代方案的试验。

方法

我们通过检索 MEDLINE、EMBASE、OviSP 和 ISI Web of Science 数据库,更新了之前的两项系统评价,检索时间为数据库建立至 2021 年 7 月。我们还在世界卫生组织国际临床试验注册平台上搜索了截至 2021 年 7 月正在进行的试验。筛选标题和摘要以确定相关试验。两名审查员独立审查并同意纳入的试验。

结果

血浆 TXA 浓度超过 10mg/L 可提供接近最大程度的纤维蛋白溶解抑制,浓度超过 5mg/L 可提供部分抑制。产后妇女口服 TXA 片剂约 1 小时即可达到 5mg/L 的血浆浓度。在健康志愿者和休克创伤患者的研究中,肌内注射 TXA 在 15 分钟内达到超过 10mg/L 的血浆水平。一项试验正在进行中,以确定孕妇肌内注射和口服溶液 TXA 的药代动力学。

结论

健康志愿者和休克创伤患者的肌内 TXA 迅速达到治疗浓度。口服 TXA 片剂在产后妇女中达到最低治疗浓度需要太长时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f3/9327714/a492c4dc9529/IJGO-158-40-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f3/9327714/a492c4dc9529/IJGO-158-40-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f3/9327714/a492c4dc9529/IJGO-158-40-g001.jpg

相似文献

1
Alternative routes to intravenous tranexamic acid for postpartum hemorrhage: A systematic search and narrative review.静脉用氨甲环酸治疗产后出血的替代途径:系统检索和叙述性综述。
Int J Gynaecol Obstet. 2022 Jun;158 Suppl 1(Suppl 1):40-45. doi: 10.1002/ijgo.14201.
2
What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies.抑制纤维蛋白溶解需要何种浓度的氨甲环酸?一项药效学研究的系统评价
Blood Coagul Fibrinolysis. 2019 Jan;30(1):1-10. doi: 10.1097/MBC.0000000000000789.
3
Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers.氨甲环酸静脉、肌肉和口服给药后的药代动力学:健康志愿者的前瞻性、随机、交叉试验。
Br J Anaesth. 2022 Mar;128(3):465-472. doi: 10.1016/j.bja.2021.10.054. Epub 2022 Jan 5.
4
Antifibrinolytic drugs for treating primary postpartum haemorrhage.用于治疗原发性产后出血的抗纤溶药物。
Cochrane Database Syst Rev. 2018 Feb 20;2(2):CD012964. doi: 10.1002/14651858.CD012964.
5
Alternative routes for tranexamic acid treatment in obstetric bleeding (WOMAN-PharmacoTXA trial): a randomised trial and pharmacological study in caesarean section births.氨甲环酸治疗产科出血的替代途径(WOMAN-PharmacoTXA 试验):剖宫产分娩中的随机试验和药理学研究。
BJOG. 2023 Sep;130(10):1177-1186. doi: 10.1111/1471-0528.17455. Epub 2023 Apr 5.
6
Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised placebo-controlled trial (I'M WOMAN).氨甲环酸经肌内或静脉途径用于预防高危产妇产后出血:一项随机安慰剂对照试验(I'M WOMAN)。
Trials. 2023 Dec 3;24(1):782. doi: 10.1186/s13063-023-07687-1.
7
Tranexamic acid as adjuvant treatment for postpartum hemorrhage: a systematic review protocol.氨甲环酸作为产后出血辅助治疗的系统评价方案
JBI Database System Rev Implement Rep. 2019 Aug;17(8):1565-1572. doi: 10.11124/JBISRIR-2017-003978.
8
Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers.健康志愿者静脉、肌肉、皮下和口服给予氨甲环酸后的药代动力学的基于生理学的模型建立。
Eur J Pharm Sci. 2021 Sep 1;164:105893. doi: 10.1016/j.ejps.2021.105893. Epub 2021 Jun 1.
9
Tranexamic acid for treatment of primary postpartum hemorrhage after vaginal delivery: a systematic review and meta-analysis of randomized controlled trials.氨甲环酸治疗阴道分娩后原发性产后出血:一项随机对照试验的系统评价和荟萃分析
J Matern Fetal Neonatal Med. 2020 Mar;33(5):869-874. doi: 10.1080/14767058.2018.1500544. Epub 2018 Sep 10.
10
Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions.抗纤维蛋白溶解疗法用于预防接受小型口腔手术或拔牙的抗凝剂使用者的口腔出血。
Cochrane Database Syst Rev. 2018 Jul 2;7(7):CD012293. doi: 10.1002/14651858.CD012293.pub2.

引用本文的文献

1
Uptake of orally administered tranexamic acid in women during active labor: A pilot intervention study on prophylactic treatment of postpartum hemorrhage.活跃期分娩女性口服氨甲环酸的吸收情况:一项关于产后出血预防性治疗的试点干预研究。
Acta Obstet Gynecol Scand. 2025 Jul;104(7):1347-1356. doi: 10.1111/aogs.15129. Epub 2025 Apr 24.
2
Traumatic bleeding and mortality in mice are intensified by iron deficiency anemia and can be rescued with tranexamic acid.缺铁性贫血会加剧小鼠的创伤性出血和死亡率,而氨甲环酸可以挽救这种情况。
Res Pract Thromb Haemost. 2024 Aug 8;8(6):102543. doi: 10.1016/j.rpth.2024.102543. eCollection 2024 Aug.

本文引用的文献

1
Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers.氨甲环酸静脉、肌肉和口服给药后的药代动力学:健康志愿者的前瞻性、随机、交叉试验。
Br J Anaesth. 2022 Mar;128(3):465-472. doi: 10.1016/j.bja.2021.10.054. Epub 2022 Jan 5.
2
WOMAN-PharmacoTXA trial: Study protocol for a randomised controlled trial to assess the pharmacokinetics and pharmacodynamics of intramuscular, intravenous and oral administration of tranexamic acid in women giving birth by caesarean section.女性-氨甲环酸药物试验:一项随机对照试验的研究方案,旨在评估剖宫产分娩女性肌肉注射、静脉注射和口服氨甲环酸的药代动力学和药效学。
Wellcome Open Res. 2021 Jun 16;6:157. doi: 10.12688/wellcomeopenres.16884.1. eCollection 2021.
3
Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers.健康志愿者静脉、肌肉、皮下和口服给予氨甲环酸后的药代动力学的基于生理学的模型建立。
Eur J Pharm Sci. 2021 Sep 1;164:105893. doi: 10.1016/j.ejps.2021.105893. Epub 2021 Jun 1.
4
Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression.静脉注射氨甲环酸与血栓栓塞事件及死亡率的关联:一项系统评价、荟萃分析和Meta回归分析
JAMA Surg. 2021 Apr 14;156(6):e210884. doi: 10.1001/jamasurg.2021.0884.
5
Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator-induced hyperfibrinolysis in full-term pregnant women: a prospective interventional study.足月孕妇组织型纤溶酶原激活物诱导的高纤维蛋白溶解抑制 95%时的氨甲环酸有效浓度:一项前瞻性干预研究。
Blood Coagul Fibrinolysis. 2021 Apr 1;32(3):186-193. doi: 10.1097/MBC.0000000000001015.
6
Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women.静脉注射氨甲环酸预防孕妇出血的最佳方法。
Am J Obstet Gynecol. 2021 Jul;225(1):85.e1-85.e11. doi: 10.1016/j.ajog.2020.11.035. Epub 2020 Nov 26.
7
Pharmacokinetics of intramuscular tranexamic acid in bleeding trauma patients: a clinical trial.肌内注射氨甲环酸治疗创伤出血患者的药代动力学:一项临床试验。
Br J Anaesth. 2021 Jan;126(1):201-209. doi: 10.1016/j.bja.2020.07.058. Epub 2020 Sep 30.
8
Plasma Concentrations of Tranexamic Acid in Postpartum Women After Oral Administration.口服氨甲环酸后产后妇女的血浆浓度。
Obstet Gynecol. 2020 Apr;135(4):945-948. doi: 10.1097/AOG.0000000000003750.
9
Anatomical and physiological alterations of pregnancy.妊娠的解剖学和生理学改变。
J Pharmacokinet Pharmacodyn. 2020 Aug;47(4):271-285. doi: 10.1007/s10928-020-09677-1. Epub 2020 Feb 6.
10
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.氨甲环酸对急性创伤性脑损伤患者死亡、残疾、血管阻塞事件和其他并发症的影响(CRASH-3):一项随机、安慰剂对照试验。
Lancet. 2019 Nov 9;394(10210):1713-1723. doi: 10.1016/S0140-6736(19)32233-0. Epub 2019 Oct 14.